Table 2 |
||
|
Genotype and allele distribution of the C+1354T single nucleotide polymorphism in patients with systemic sclerosis and in matched control individuals |
||
| C+1354T single nucleotide polymorphism |
Systemic sclerosis patients (n = 115) |
Control individuals (n = 140) |
|
|
||
| Genotype* |
||
| CC |
103 (89.6) |
108 (77.1) |
| CT |
12 (10.4) |
30 (21.4) |
| TT |
0 (0) |
2 (1.4) |
| Allele** |
||
| C |
218 (94.8) |
246 (87.6) |
| T |
12 (5.2) |
34 (12.4) |
|
|
||
|
Data presented as n (%).*P < 0.05. **P < 0.01 (chi-square test). |
||
|
Beretta et al. Arthritis Research & Therapy 2008 10:R103 doi:10.1186/ar2495 |
||
